Phosphatidylserine is a compound that contains serine and is mainly found in nerve cell membranes where it helps support brain and nerve cell function. Phosphatidylserine supplements are commonly used to improve symptoms of dementia and Alzheimer's disease. It can also boost energy levels, support muscle recovery after exercise, and enhance focus and memory. The global phosphatidylserine market is estimated to be valued at US$2.62 million in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The increasing use of phosphatidylserine in dietary supplements is expected to provide growth opportunities to the market over the forecast period. Phosphatidylserine is widely used in dietary supplements for cognitive health and sports nutrition. Aging populations have increased the demand for supplements that promote brain health and prevent cognitive decline. Furthermore, increasing focus on physical fitness across age groups has boosted the consumption of supplements by athletes and bodybuilders for faster muscle recovery and building strength. Supplement manufacturers are launching new phosphatidylserine based offerings for brain and body health that are driving the market growth. Rising awareness about the benefits of phosphatidylserine among consumers will continue to support its demand in the global dietary supplements industry.

Porter's Analysis
Threat of new entrants: Low barriers to entry for Phosphatidylserine market means new companies can enter easily. However, established brands have brand loyalty and economy of scale advantages.

Bargaining power of buyers: Large buyers like pharmaceutical companies have significant bargaining power to negotiate lower prices due to the bulk orders. Individual consumers have low bargaining power.

Bargaining power of suppliers: A few major suppliers exist for key raw materials like soybean, which gives them stronger negotiation position against buyers.

Threat of new substitutes: Alternatives like lecithin, choline, and uridine exist but phosphatidylserine has unique bioavailability benefits, reducing threat from substitutes.

Competitive rivalry: Big brands compete on pricing and new product innovations due to the competitive nature of the market.

SWOT Analysis
Strengths: Promising health benefits of PS in brain health and cognition. Growing geriatric population prone to neurodegeneration increases demand.

Weaknesses: Limited manufacturing facilities for PS globally increases supply risks. High prices limit mass consumption.

Opportunities: Scope for PS in treating depression, obesity and other ailments expands market. Growth regions in Asia Pacific and South America yet to be tapped.

Threats: Negative research findings on PS efficacy can impact sales. Stringent regulations on health claims delay product development and marketing.

Key Takeaways
The Global Phosphatidylserine Market Demand is expected to witness high growth over the forecast period of 2024 to 2031.

The North American region currently dominates the market owing to rising health consciousness. Europe follows as the second largest region due to a large elderly demographic prone to cognitive issues.

Key players operating in the Phosphatidylserine market are Norden Pharma GmbH, Chemi Nutra, Lonza, Novastell, and Lipoid. Norden Pharma is the market leader known for its branded brain health supplement Bergamon. Lonza is a major supplier and manufacturer of PS for pharmaceutical and nutritional applications.

For more insights, Read- https://www.ukwebwire.com/phosphatidylserine-market-demand-share-analysis/

Get more insights on this topic: https://lotstoexpress.com/whispers-of-the-genomics-exploring-the-secrets-hidden-in-every-stand/